Publisher: DelveInsight
Category: Prescription Drugs

Prescription Drugs market research reports by DelveInsight

(642 reports matching your criteria)
    • Rexulti and Zoloft Combination, Emerging Drug Insight and Market Forecast – 2032

      Rexulti and Zoloft Combination, Emerging Drug Insight and Market Forecast – 2032 “Rexulti and Zoloft Combination, Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Rexulti and Zoloft combination for Post-traumatic Stress Disorder in seven major markets. A ... Read More

    • XOLAIR Emerging Drug Insight and Market Forecast – 2032

      XOLAIR Emerging Drug Insight and Market Forecast – 2032 “XOLAIR Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about XOLAIR for Food Allergy in the 7MM. A detailed picture of the XOLAIR for Food Allergy in the 7MM, i.e., United States, EU5 (Germany, France, ... Read More

    • REPLAGAL, Drug Insight and Market Forecast – 2032

      REPLAGAL, Drug Insight and Market Forecast – 2032 “REPLAGAL, Drug Insight and Market Forecast – 2032” report provides comprehensive insights about REPLAGAL for Fabry Disease in the 7MM. A detailed picture of the REPLAGAL for Fabry Disease in the 7MM, i.e., United States, EU5 (Germany, France, Italy, ... Read More

    • Viralym-M Emerging Drug Insight and Market Forecast – 2032

      Viralym-M Emerging Drug Insight and Market Forecast – 2032 “Viralym-M Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Viralym-M for Hemorrhagic Cystitis in the 7MM. A detailed picture of the Viralym-M for Hemorrhagic Cystitis in the 7MM, i.e., United St ... Read More

    • SAPHNELO Emerging Drug Insight and Market Forecast – 2032

      SAPHNELO Emerging Drug Insight and Market Forecast – 2032 “SAPHNELO Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about SAPHNELO for lupus nephritis in the seven major markets. A detailed picture of the SAPHNELO for lupus nephritis in the 7MM, i.e., United ... Read More

    • Fasinumab Emerging Drug Insight and Market Forecast – 2032

      Fasinumab Emerging Drug Insight and Market Forecast – 2032 “Fasinumab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about fasinumab for knee osteoarthritis (OA) in the seven major markets. A detailed picture of the fasinumab for knee osteoarthritis in the 7 ... Read More

    • Verdiperstat Emerging Drug Insight and Market Forecast – 2032

      Verdiperstat Emerging Drug Insight and Market Forecast – 2032 “Verdiperstat Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Verdiperstat for Amyotrophic Lateral Sclerosis in the 7MM. A detailed picture of the Verdiperstat for Amyotrophic Lateral Scleros ... Read More

    • CA002 Emerging Drug Insight and Market Forecast – 2032

      CA002 Emerging Drug Insight and Market Forecast – 2032 “CA002 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about CA002 for Food Allergy in the 7MM. A detailed picture of the CA002 for Food Allergy in the 7MM, i.e., United States, EU5 (Germany, France, Ital ... Read More

    • BNC210, Emerging Drug Insight and Market Forecast – 2032

      BNC210, Emerging Drug Insight and Market Forecast – 2032 “BNC210, Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about BNC210 for Post-traumatic Stress Disorder in seven major markets. A detailed picture of the BNC210 for Post-traumatic Stress Disorder in 7M ... Read More

    • XOLAIR Drug Insight and Market Forecast – 2032

      XOLAIR Drug Insight and Market Forecast – 2032 “XOLAIR Drug Insight and Market Forecast – 2032” report provides comprehensive insights about XOLAIR for Nasal Polyposis in the 7MM. A detailed picture of the XOLAIR for Nasal Polyposis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain ... Read More

    • PENTHROX Drug Insight and Market Forecast – 2032

      PENTHROX Drug Insight and Market Forecast – 2032 “PENTHROX Drug Insight and Market Forecast – 2032” report provides comprehensive insights about PENTHROX for Postoperative Pain in the 7MM. A detailed picture of the PENTHROX for Postoperative Pain in the 7MM, i.e., United States, EU5 (Germany, France ... Read More

    • Venglustat, Emerging Drug Insight and Market Forecast – 2032

      Venglustat, Emerging Drug Insight and Market Forecast – 2032 “Venglustat, Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Venglustat for Fabry Disease in the 7MM. A detailed picture of the Venglustat for Fabry Disease in the 7MM, i.e., United States, EU ... Read More

    • TYSABRI (Natalizumab), Drug Insight and Market Forecast – 2032

      TYSABRI (Natalizumab), Drug Insight and Market Forecast – 2032 “TYSABRI (Natalizumab), Drug Insight and Market Forecast – 2032” report provides comprehensive insights about TYSABRI (Natalizumab) for Crohn’s disease (CD) in the 7MM. A detailed picture of the TYSABRI (Natalizumab) for Crohn’s disease ... Read More

    • EPI-589 Emerging Drug Insight and Market Forecast – 2032

      EPI-589 Emerging Drug Insight and Market Forecast – 2032 “EPI-589 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about EPI-589 for Amyotrophic Lateral Sclerosis in the 7MM. A detailed picture of the EPI-589 for Amyotrophic Lateral Sclerosis in the 7MM, i.e., ... Read More

    • NUCALA Drug Insight and Market Forecast – 2032

      NUCALA Drug Insight and Market Forecast – 2032 “NUCALA Drug Insight and Market Forecast – 2032” report provides comprehensive insights about NUCALA for Nasal Polyposis in the 7MM. A detailed picture of the NUCALA for Nasal Polyposis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain ... Read More

    • Masitinib Emerging Drug Insight and Market Forecast – 2032

      Masitinib Emerging Drug Insight and Market Forecast – 2032 “Masitinib Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about masitinib for Amyotrophic Lateral Sclerosis in seven major markets. A detailed picture of the masitinib for Amyotrophic Lateral Scleros ... Read More

    • KUVAN (Sapropterin Hydrochloride), Drug Insight and Market Forecast – 2032

      KUVAN (Sapropterin Hydrochloride), Drug Insight and Market Forecast – 2032 KUVAN (Sapropterin Hydrochloride), Drug Insight and Market Forecast – 2032” report provides comprehensive insights about KUVAN (Sapropterin Hydrochloride) for Phenylketonuria (PKU) in the 7MM. A detailed picture of the KUVAN ... Read More

    • HALNEURON Emerging Drug Insight and Market Forecast – 2032

      HALNEURON Emerging Drug Insight and Market Forecast – 2032 “HALNEURON Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about HALNEURON for Chemotherapy-induced Peripheral Neuropathy in the 7MM. A detailed picture of the HALNEURON for Chemotherapy-induced Perip ... Read More

    • AT-1501 Emerging Drug Insight and Market Forecast – 2032

      AT-1501 Emerging Drug Insight and Market Forecast – 2032 “AT-1501 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about AT-1501 for Amyotrophic Lateral Sclerosis in seven major markets. A detailed picture of the AT-1501 for Amyotrophic Lateral Sclerosis in 7M ... Read More

    • SLS-005 Emerging Drug Insight and Market Forecast – 2032

      SLS-005 Emerging Drug Insight and Market Forecast – 2032 “SLS-005 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about SLS-005 for Amyotrophic Lateral Sclerosis in the 7MM. A detailed picture of the SLS-005 for Amyotrophic Lateral Sclerosis in the 7MM, i.e., ... Read More

    • MN-166 (Ibudilast) Emerging Drug Insight and Market Forecast – 2032

      MN-166 (Ibudilast) Emerging Drug Insight and Market Forecast – 2032 “MN-166 (Ibudilast) Emerging Drug Insight and Market Forecast – 2032”report provides comprehensive insights about MN-166 (Ibudilast) for Amyotrophic Lateral Sclerosis in seven major markets. A detailed picture of the MN-166 (Ibudila ... Read More

    • CNP-201 Emerging Drug Insight and Market Forecast – 2032

      CNP-201 Emerging Drug Insight and Market Forecast – 2032 “CNP-201 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about CNP-201 for Food Allergy in the 7MM. A detailed picture of the CNP-201 for Food Allergy in the 7MM, i.e., United States, EU5 (Germany, Fran ... Read More

    • Cimdelirsen Emerging Drug Insight and Market Forecast – 2032

      Cimdelirsen Emerging Drug Insight and Market Forecast – 2032 “Cimdelirsen Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about cimdelirsen for acromegaly in the seven major markets. A detailed picture of the cimdelirsen for acromegaly in the 7MM, i.e., Unite ... Read More

    • WAKIX (Pitolisant), Drug Insight and Market Forecast – 2032

      WAKIX (Pitolisant), Drug Insight and Market Forecast – 2032 “WAKIX (Pitolisant), Drug Insight and Market Forecast – 2032” report provides comprehensive insights about WAKIX (Pitolisant) for Excessive Daytime Sleepiness (EDS) in the 7MM. A detailed picture of the WAKIX (Pitolisant) for Excessive Dayt ... Read More

    • Ampion Emerging Drug Insight and Market Forecast – 2032

      Ampion Emerging Drug Insight and Market Forecast – 2032 “Ampion Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about ampion for knee osteoarthritis (OA) in the seven major markets. A detailed picture of the ampion for knee osteoarthritis in the 7MM, i.e., Un ... Read More

6 7 8 9 10 11 12 13 14 15

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings